INNOVATION

Discovery of cancer-specific target "Transglutaminase2"

COLLABORATION

Strategic Alliance for Strengthening Pipeline

BUSINESS

Licensing-out Business model after Clinical 2a

Chung, Hyuncheol(Chief Scientific Officer/President)

- Professor Emeritus of Oncology, Yonsei University 

Ra, Sun Young(Non-Executive Director)

- Professor of Oncology, Yonsei University 

Kim, Tae Won(Non-Executive Director)

- Professor of Oncology,  Seoul Asan Hospital 

Jeong, Heon(Advisor)

- CEO at Aston Science 

Kim, Seonghwan(Advisor)

- Senior researcher of ‌Korea Research Institute of Chemical Technology‌

Shin, Young Geun(Advisor)

- Professor of Chungnam National University College of Pharmacy 

Im, Seock Ah(Advisor)

- Professor of blood oncology, Seoul National University 

Park, Kyong Hwa(Advisor)

- Professor of hemato-oncology, Korea University Anam Hospital

Chung, Hyuncheol
(Chief Scientific Officer)

Cho, Eunyi
(R & D Team Leader)

Im, Eunji
(R&D)

Jo, Yerin
(R&D Planning)

Moon, Byeonghak
(R&D)

Kim, hyeonjoo
(R&D)